Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance
Noralyn B. Mañucat‐Tan, Khalil Saadipour, Yan‐Jiang Wang, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 2, pp. 812-830
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential
Li-Na Gao, Yun Zhang, Keenan Sterling, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 332
APP lysine 612 lactylation ameliorates amyloid pathology and memory decline in Alzheimer’s disease
Qiuyun Tian, Junjie Li, Bin Wu, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 1
Closed Access | Times Cited: 3
Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Mabel Seto, Rebecca L. Weiner, Logan Dumitrescu, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 98
Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc
Jae‐Young Koh, Hana Kim, Jung Jin Hwang, et al.
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 96
Sphingolipids in Alzheimer's disease, how can we target them?
Simone M. Crivelli, Caterina Giovagnoni, Lars Visseren, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 214-231
Closed Access | Times Cited: 74
Unraveling the Complexity of Human Brain: Structure, Function in Healthy and Disease States
Omme Fatema Sultana, Madhuri Bandaru, Md. Ariful Islam, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102414-102414
Closed Access | Times Cited: 14
Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers
Arezoo Mirzaie, Hassan Nasrollahpour, Balal Khalilzadeh, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117174-117174
Closed Access | Times Cited: 17
Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles
Zhiqiang Deng, Dong Yu, Xiaoting Zhou, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1688-1706
Open Access | Times Cited: 33
Alzheimer’s Disease “Non-amyloidogenic” p3 Peptide Revisited: A Case for Amyloid-α
Ariel J. Kuhn, Benjamin Abrams, Stella Knowlton, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 11, pp. 1539-1544
Open Access | Times Cited: 33
Targeting Caspases 3/6 and Cathepsins L/B May Decrease Laminopathy-Induced Apoptosis in Alzheimer’s Disease
Auob Rustamzadeh, Abbas Tafakhori, Armin Ariaei, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. 1, pp. 211-221
Closed Access | Times Cited: 4
In vivo induction of membrane damage by β-amyloid peptide oligomers
Carl Julien, Colson Tomberlin, Christine M. Roberts, et al.
Acta Neuropathologica Communications (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 35
TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer’s disease pathologies
Yiyuan Xia, Zhi-Hao Wang, Pai Liu, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 2943-2963
Open Access | Times Cited: 27
Post-Translational Modifications of BACE1 in Alzheimer's Disease
Wen Wen, Ping Li, Panwang Liu, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 1, pp. 211-222
Open Access | Times Cited: 18
Eta-secretase-like processing of the amyloid precursor protein (APP) by the rhomboid protease RHBDL4
Ylauna Christine Mégane Penalva, Sandra Paschkowsky, Sherilyn Junelle Recinto, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 8, pp. 107541-107541
Open Access | Times Cited: 2
DEAD-Box Helicase 17 Promotes Amyloidogenesis by Regulating BACE1 Translation
Yue Liu, Gui‐Feng Zhou, Song Li, et al.
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 745-745
Open Access | Times Cited: 6
Sensory gamma entrainment: Impact on amyloid protein and therapeutic mechanism
Jiaying Hu, Leyan Zheng, Ziyu Guan, et al.
Brain Research Bulletin (2023) Vol. 202, pp. 110750-110750
Open Access | Times Cited: 6
Effects of surface nanopatterning on internalization and amyloid aggregation of the fragment 264-277 of Nucleophosmin 1
Concetta Di Natale, Carlo F. Natale, Daniele Florio, et al.
Colloids and Surfaces B Biointerfaces (2020) Vol. 197, pp. 111439-111439
Closed Access | Times Cited: 16
The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer’s Disease Mouse Model
Valentina Latina, Anna Atlante, Francesca Malerba, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9683-9683
Open Access | Times Cited: 4
Endosomal trafficking and related genetic underpinnings as a hub in Alzheimer's disease
Adriana Limone, Iolanda Veneruso, Valeria D’Argenio, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 10, pp. 3803-3815
Open Access | Times Cited: 6
Expression of Amyloid Precursor Protein, Caveolin-1, Alpha-, Beta-, and Gamma-Secretases in Penumbra Cells after Photothrombotic Stroke and Evaluation of Neuroprotective Effect of Secretase and Caveolin-1 Inhibitors
Svetlana Sharifulina, Andrey Khaitin, Valeria Guzenko, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2655-2655
Open Access | Times Cited: 3
Steroidogenic Acute Regulatory Protein Mediated Variations of Gender-Specific Sex Neurosteroids in Alzheimer’s Disease: Relevance to Hormonal Imbalance
Pulak R. Manna, Shengping Yang, Claudio Manna, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 169, pp. 105969-105969
Closed Access
The effects of a bioavailable curcumin formulation on Alzheimer's disease pathologies: A potential risk for neuroinflammation
Shaun Cade, Clive A. Prestidge, Xin‐Fu Zhou, et al.
Ibrain (2024) Vol. 10, Iss. 4, pp. 500-518
Open Access
SPIN90 Deficiency Ameliorates Amyloid β Accumulation by Regulating APP Trafficking in AD Model Mice
Youngsoo Oh, Wongyoung Lee, So Hee Kim, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10563-10563
Open Access | Times Cited: 2
Eta-secretase-like processing of the amyloid precursor protein (APP) by RHBDL4
Penalva Ylauna Christine Megane, Sandra Paschkowsky, Sherilyn Junelle Recinto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Inhibition of caspases 3/6 and cathepsins L/B decreases apoptosis caused by laminopathy in Alzheimer’s disease
Auob Rustamzadeh, Abbas Tafakhori, Armin Ariaei, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top